Psyence Biomedical PBM
NASDAQ PBM
$4.15 -0.37 (-8.19%)
As of: Oct 22, 2026 · 12:09 PM EDT

Psyence Biomedical (PBM) Non-Current Deffered Revenue (2022 - 2023)

Updated

Psyence Biomedical's Non-Current Deffered Revenue came in at $13.1 million for the quarter ended Sep 30, 2023.

Analysis

Psyence Biomedical (PBM) Non-Current Deffered Revenue (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,170.99 Bn 1,139.58 Bn 19.71 Bn -
2 Johnson & Johnson 642.25 Bn 560.77 Bn 17.26 Bn -
3 AbbVie 502.08 Bn 475.19 Bn 12.70 Bn -
4 Merck 375.61 Bn 329.99 Bn 12.21 Bn -
5 Novartis Ag 302.76 Bn 266.75 Bn 11.24 Bn -
6 Astrazeneca 268.66 Bn 242.35 Bn 12.86 Bn -
7 Amgen 241.98 Bn 197.38 Bn 7.24 Bn -
8 Gilead Sciences 193.37 Bn 167.57 Bn 6.22 Bn -
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Psyence Biomedical 2.30 Mn -20.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 13.10 Mn
Dec 31, 2022 13.10 Mn
API Access

Psyence Biomedical Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PBM&period=max&api_key=YOUR_API_KEY